nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—Panic reaction—Varenicline—nicotine dependence	0.105	0.238	CcSEcCtD
Epinephrine—Mydriasis—Varenicline—nicotine dependence	0.0263	0.0599	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0232	0.0529	CcSEcCtD
Epinephrine—Blood pressure increased—Varenicline—nicotine dependence	0.021	0.0478	CcSEcCtD
Epinephrine—Disorientation—Varenicline—nicotine dependence	0.017	0.0388	CcSEcCtD
Epinephrine—Hypoglycaemia—Varenicline—nicotine dependence	0.0156	0.0356	CcSEcCtD
Epinephrine—Cerebrovascular accident—Varenicline—nicotine dependence	0.0155	0.0354	CcSEcCtD
Epinephrine—Psychotic disorder—Varenicline—nicotine dependence	0.0149	0.0339	CcSEcCtD
Epinephrine—Hypokalaemia—Varenicline—nicotine dependence	0.0139	0.0316	CcSEcCtD
Epinephrine—Hyperglycaemia—Varenicline—nicotine dependence	0.0119	0.0271	CcSEcCtD
Epinephrine—Acute coronary syndrome—Varenicline—nicotine dependence	0.0116	0.0264	CcSEcCtD
Epinephrine—Myocardial infarction—Varenicline—nicotine dependence	0.0115	0.0262	CcSEcCtD
Epinephrine—Hypoaesthesia—Varenicline—nicotine dependence	0.0105	0.0239	CcSEcCtD
Epinephrine—Hallucination—Varenicline—nicotine dependence	0.0105	0.0239	CcSEcCtD
Epinephrine—Arrhythmia—Varenicline—nicotine dependence	0.00941	0.0214	CcSEcCtD
Epinephrine—Mental disorder—Varenicline—nicotine dependence	0.00923	0.021	CcSEcCtD
Epinephrine—Erythema—Varenicline—nicotine dependence	0.00917	0.0209	CcSEcCtD
Epinephrine—ADRBK1—cardiovascular system—nicotine dependence	0.00847	0.185	CbGeAlD
Epinephrine—Agitation—Varenicline—nicotine dependence	0.00843	0.0192	CcSEcCtD
Epinephrine—Palpitations—Varenicline—nicotine dependence	0.0081	0.0185	CcSEcCtD
Epinephrine—Hypertension—Varenicline—nicotine dependence	0.00792	0.018	CcSEcCtD
Epinephrine—Chest pain—Varenicline—nicotine dependence	0.00781	0.0178	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00775	0.0177	CcSEcCtD
Epinephrine—Nervous system disorder—Varenicline—nicotine dependence	0.00734	0.0167	CcSEcCtD
Epinephrine—Tachycardia—Varenicline—nicotine dependence	0.0073	0.0166	CcSEcCtD
Epinephrine—Skin disorder—Varenicline—nicotine dependence	0.00727	0.0166	CcSEcCtD
Epinephrine—Hyperhidrosis—Varenicline—nicotine dependence	0.00724	0.0165	CcSEcCtD
Epinephrine—Insomnia—Varenicline—nicotine dependence	0.00677	0.0154	CcSEcCtD
Epinephrine—Somnolence—Varenicline—nicotine dependence	0.00665	0.0152	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00646	0.0147	CcSEcCtD
Epinephrine—PAH—brain—nicotine dependence	0.00545	0.119	CbGeAlD
Epinephrine—Norepinephrine—DRD2—nicotine dependence	0.00513	0.341	CrCbGaD
Epinephrine—L-DOPA—DRD2—nicotine dependence	0.00513	0.341	CrCbGaD
Epinephrine—Dizziness—Varenicline—nicotine dependence	0.00495	0.0113	CcSEcCtD
Epinephrine—Dopamine—DRD2—nicotine dependence	0.00477	0.317	CrCbGaD
Epinephrine—Vomiting—Varenicline—nicotine dependence	0.00476	0.0108	CcSEcCtD
Epinephrine—Nausea—Varenicline—nicotine dependence	0.00445	0.0101	CcSEcCtD
Epinephrine—ADRBK1—brain—nicotine dependence	0.00416	0.0909	CbGeAlD
Epinephrine—ADRB1—cardiovascular system—nicotine dependence	0.00354	0.0775	CbGeAlD
Epinephrine—ADRA1A—cardiovascular system—nicotine dependence	0.0028	0.0613	CbGeAlD
Epinephrine—ADRA1B—brain—nicotine dependence	0.00245	0.0535	CbGeAlD
Epinephrine—ADRA1D—brain—nicotine dependence	0.00239	0.0523	CbGeAlD
Epinephrine—CYP2C9—cardiovascular system—nicotine dependence	0.0022	0.0481	CbGeAlD
Epinephrine—ADRA2C—midbrain—nicotine dependence	0.00209	0.0456	CbGeAlD
Epinephrine—SLC22A5—midbrain—nicotine dependence	0.002	0.0437	CbGeAlD
Epinephrine—SLC22A2—Neuronal System—GABRA4—nicotine dependence	0.00195	0.00391	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00191	0.00383	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—CHRNB4—nicotine dependence	0.00187	0.00375	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—FGD1—nicotine dependence	0.00187	0.00374	CbGpPWpGaD
Epinephrine—SLC22A2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00185	0.0037	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—WASF2—nicotine dependence	0.00183	0.00365	CbGpPWpGaD
Epinephrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00182	0.00364	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.00182	0.00364	CbGpPWpGaD
Epinephrine—SLC22A1—brain—nicotine dependence	0.00181	0.0395	CbGeAlD
Epinephrine—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00179	0.00358	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—WASF1—nicotine dependence	0.00175	0.0035	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.00175	0.00349	CbGpPWpGaD
Epinephrine—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00174	0.00348	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—CHRNA5—nicotine dependence	0.00174	0.00348	CbGpPWpGaD
Epinephrine—ADRB1—brain—nicotine dependence	0.00174	0.038	CbGeAlD
Epinephrine—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00173	0.00345	CbGpPWpGaD
Epinephrine—PAH—Metabolism—CYP2A7—nicotine dependence	0.0017	0.0034	CbGpPWpGaD
Epinephrine—SLC22A5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00167	0.00334	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00166	0.00333	CbGpPWpGaD
Epinephrine—ADRA2A—midbrain—nicotine dependence	0.00166	0.0364	CbGeAlD
Epinephrine—ADRB3—GPCR downstream signaling—FGD1—nicotine dependence	0.00165	0.00331	CbGpPWpGaD
Epinephrine—SLC22A2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00163	0.00326	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.00162	0.00325	CbGpPWpGaD
Epinephrine—ADRB3—GPCR ligand binding—OPRM1—nicotine dependence	0.00157	0.00314	CbGpPWpGaD
Epinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00157	0.00314	CbGpPWpGaD
Epinephrine—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00156	0.00311	CbGpPWpGaD
Epinephrine—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00153	0.00305	CbGpPWpGaD
Epinephrine—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00152	0.00304	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—FGD1—nicotine dependence	0.0015	0.003	CbGpPWpGaD
Epinephrine—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00149	0.00298	CbGpPWpGaD
Epinephrine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00148	0.00296	CbGpPWpGaD
Epinephrine—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00147	0.00294	CbGpPWpGaD
Epinephrine—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00145	0.0029	CbGpPWpGaD
Epinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00143	0.00286	CbGpPWpGaD
Epinephrine—ADRA2C—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00143	0.00285	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—CHRNA3—nicotine dependence	0.00142	0.00284	CbGpPWpGaD
Epinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00142	0.00283	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TAS2R16—nicotine dependence	0.00141	0.00282	CbGpPWpGaD
Epinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0014	0.0028	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—AKR1B10—nicotine dependence	0.00139	0.00279	CbGpPWpGaD
Epinephrine—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00138	0.00276	CbGpPWpGaD
Epinephrine—ADRA1A—brain—nicotine dependence	0.00138	0.0301	CbGeAlD
Epinephrine—ADRA1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00137	0.00274	CbGpPWpGaD
Epinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00135	0.00269	CbGpPWpGaD
Epinephrine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00133	0.00266	CbGpPWpGaD
Epinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00132	0.00265	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.00132	0.00265	CbGpPWpGaD
Epinephrine—ADRA2C—brain—nicotine dependence	0.00131	0.0286	CbGeAlD
Epinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0013	0.0026	CbGpPWpGaD
Epinephrine—SLC22A5—brain—nicotine dependence	0.00126	0.0274	CbGeAlD
Epinephrine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.00126	0.00251	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00125	0.0025	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—CHRNB2—nicotine dependence	0.00125	0.0025	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.00125	0.00249	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00124	0.00248	CbGpPWpGaD
Epinephrine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00124	0.00247	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00123	0.00245	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00122	0.00245	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00121	0.00243	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0012	0.0024	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.00117	0.00233	CbGpPWpGaD
Epinephrine—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00116	0.00232	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00116	0.00231	CbGpPWpGaD
Epinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00116	0.00231	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00114	0.00228	CbGpPWpGaD
Epinephrine—ADRB3—GPCR ligand binding—DRD2—nicotine dependence	0.00114	0.00227	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00114	0.00227	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.00114	0.00227	CbGpPWpGaD
Epinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00114	0.00227	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00113	0.00227	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TAS2R16—nicotine dependence	0.00113	0.00226	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00113	0.00225	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00112	0.00223	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00111	0.00222	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00111	0.00221	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—FGD1—nicotine dependence	0.00111	0.00221	CbGpPWpGaD
Epinephrine—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.0011	0.00221	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00108	0.00215	CbGpPWpGaD
Epinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00108	0.00215	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—WASF2—nicotine dependence	0.00106	0.00213	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.00106	0.00212	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00105	0.0021	CbGpPWpGaD
Epinephrine—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00105	0.0021	CbGpPWpGaD
Epinephrine—ADRA2A—brain—nicotine dependence	0.00105	0.0229	CbGeAlD
Epinephrine—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00104	0.00207	CbGpPWpGaD
Epinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00103	0.00207	CbGpPWpGaD
Epinephrine—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.00103	0.00206	CbGpPWpGaD
Epinephrine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00103	0.00205	CbGpPWpGaD
Epinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00102	0.00205	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.00102	0.00205	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—WASF1—nicotine dependence	0.00102	0.00204	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00101	0.00202	CbGpPWpGaD
Epinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00101	0.00202	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—OPRM1—nicotine dependence	0.00101	0.00201	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000992	0.00198	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—FGD1—nicotine dependence	0.000982	0.00196	CbGpPWpGaD
Epinephrine—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00098	0.00196	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.000979	0.00196	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AKR1B10—nicotine dependence	0.000976	0.00195	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000973	0.00194	CbGpPWpGaD
Epinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000973	0.00194	CbGpPWpGaD
Epinephrine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000969	0.00194	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—FGD1—nicotine dependence	0.00096	0.00192	CbGpPWpGaD
Epinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000957	0.00191	CbGpPWpGaD
Epinephrine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000955	0.00191	CbGpPWpGaD
Epinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000942	0.00188	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000941	0.00188	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—OPRM1—nicotine dependence	0.000933	0.00187	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000925	0.00185	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000921	0.00184	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000919	0.00184	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—OPRM1—nicotine dependence	0.000913	0.00182	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000909	0.00182	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000894	0.00179	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—FGD1—nicotine dependence	0.000892	0.00178	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000889	0.00178	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—FGD1—nicotine dependence	0.000887	0.00177	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000886	0.00177	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000883	0.00177	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000878	0.00175	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—FGD1—nicotine dependence	0.000872	0.00174	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000867	0.00173	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000864	0.00173	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000854	0.00171	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.00085	0.0017	CbGpPWpGaD
Epinephrine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000838	0.00167	CbGpPWpGaD
Epinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000837	0.00167	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000825	0.00165	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00082	0.00164	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000812	0.00162	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000807	0.00161	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—OPRM1—nicotine dependence	0.000807	0.00161	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—DRD2—nicotine dependence	0.0008	0.0016	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000794	0.00159	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKR1B10—nicotine dependence	0.000784	0.00157	CbGpPWpGaD
Epinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000778	0.00155	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000755	0.00151	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000741	0.00148	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000738	0.00148	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000737	0.00147	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—DRD2—nicotine dependence	0.000727	0.00145	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000721	0.00144	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000717	0.00143	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000702	0.0014	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—WASF2—nicotine dependence	0.000688	0.00137	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	0.000675	0.00135	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	0.000671	0.00134	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.00067	0.00134	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.000669	0.00134	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000666	0.00133	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000665	0.00133	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—DRD2—nicotine dependence	0.00066	0.00132	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—WASF1—nicotine dependence	0.00066	0.00132	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TAS2R16—nicotine dependence	0.000657	0.00131	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—DRD2—nicotine dependence	0.000643	0.00128	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	0.000625	0.00125	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000621	0.00124	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.000615	0.00123	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000611	0.00122	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—OPRM1—nicotine dependence	0.000594	0.00119	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—DRD2—nicotine dependence	0.000583	0.00117	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000579	0.00116	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.000578	0.00116	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—WASF2—nicotine dependence	0.000552	0.0011	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000546	0.00109	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000543	0.00109	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—WASF1—nicotine dependence	0.000529	0.00106	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000527	0.00105	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—FGD1—nicotine dependence	0.000527	0.00105	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000526	0.00105	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000523	0.00104	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.000522	0.00104	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000516	0.00103	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—FGD1—nicotine dependence	0.000515	0.00103	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000511	0.00102	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000507	0.00101	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000505	0.00101	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—CYP2A7—nicotine dependence	0.000492	0.000984	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000488	0.000976	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	0.000488	0.000974	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00048	0.00096	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	0.00048	0.000959	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	0.000479	0.000957	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—CYP2A7—nicotine dependence	0.000479	0.000957	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—OPRM1—nicotine dependence	0.000477	0.000953	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000475	0.000949	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—OPRM1—nicotine dependence	0.000469	0.000936	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	0.000465	0.00093	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000461	0.000921	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000459	0.000917	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKR1B10—nicotine dependence	0.000455	0.00091	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000443	0.000886	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000436	0.000872	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000431	0.000861	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—DRD2—nicotine dependence	0.000429	0.000858	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000427	0.000853	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.000426	0.000852	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000424	0.000847	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000419	0.000836	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000397	0.000793	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.000396	0.000791	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.000389	0.000777	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000388	0.000775	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	0.000381	0.000762	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	0.00038	0.00076	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000378	0.000755	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000376	0.000752	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—DRD2—nicotine dependence	0.000373	0.000746	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.00036	0.00072	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	0.00036	0.000719	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	0.000353	0.000705	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.00035	0.000699	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000347	0.000694	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	0.000346	0.000692	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	0.000345	0.000689	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—DRD2—nicotine dependence	0.000345	0.000689	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	0.000343	0.000686	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—DRD2—nicotine dependence	0.000339	0.000677	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—WASF2—nicotine dependence	0.000328	0.000655	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	0.000325	0.000649	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—WASF2—nicotine dependence	0.000321	0.000641	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	0.000321	0.000641	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	0.000315	0.00063	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—WASF1—nicotine dependence	0.000314	0.000628	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	0.000311	0.000622	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	0.000311	0.000621	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000309	0.000617	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—WASF1—nicotine dependence	0.000307	0.000614	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	0.000303	0.000606	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	0.000299	0.000597	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	0.000291	0.000581	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000287	0.000573	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	0.000286	0.000572	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	0.000283	0.000566	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	0.00028	0.00056	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.00028	0.00056	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—OPRM1—nicotine dependence	0.000277	0.000553	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.000265	0.00053	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	0.000262	0.000523	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.00026	0.00052	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	0.000258	0.000515	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.000254	0.000508	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000251	0.000502	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.000246	0.000493	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.000236	0.000472	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.000229	0.000458	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	0.000225	0.000449	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000215	0.000429	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000213	0.000425	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—DRD2—nicotine dependence	0.000205	0.000409	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	0.000203	0.000405	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—DRD2—nicotine dependence	0.0002	0.0004	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	0.000189	0.000378	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	0.000186	0.000372	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000166	0.000331	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	0.000166	0.000331	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	0.000154	0.000307	CbGpPWpGaD
